AI, Collaborations, Competitor News, Pharma

Tempus Announces Agreement With Janssen R&D to Leverage AI/ML and Real-World Evidence to Enhance the Discovery and Development of Oncology Therapies

Posted on

December 01, 2021 09:46 AM Eastern Standard Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced the expansion of its multi-year agreement with Janssen Research & Development, LLC (Janssen). The expanded scope is anchored in new AI-based work, in which Tempus will collaborate with a multidisciplinary…

Competitor News, Ethics, Government/Regulatory

Datavant Supports FDA Guidance with a Privacy-first Approach to Using Real World Evidence for Regulatory Decision Making

Posted on

Last week Datavant submitted comments on the recently issued FDA’s guidance that helped to clarify how real world data could be made “fit for purpose” in regulatory decision-making. In our response, we celebrated and applauded the FDA for advancing the use of real world data while highlighting a critical gap related to patient privacy….

Collaborations, Competitor News, Europe, Government/Regulatory, International

European Medicines Agency Selects Aetion to Support Safety and Efficacy Research in Europe

Posted on

BARCELONA, Spain, Dec. 1, 2021 /PRNewswire/ — The European Medicines Agency (EMA) has selected Aetion for a four-year term to support the agency’s Quality, Efficacy, and Safety Studies on Medicines. Aetion will perform pharmacoepidemiologic research for EMA, generating real-world evidence (RWE) to help measure the utilisation, safety, and efficacy of medicines used…

Academic, Europe, Industry News, International, Pharma, RWE Study

The Lancet Regional Health – Europe publishes ‘real-world evidence’ from ALK-sponsored study confirming long-term benefits of allergy immunotherapy in allergic rhinitis and asthma

Posted on

COPENHAGEN, Denmark, Dec. 1, 2021 /PRNewswire/ — ALK (ALKB: DC) (OMX: ALK B) (OMX: AKABY) (OMX: AKBLF) today announced that results from the REACT study, a large retrospective real-world study comprising more than 92,000 patients with respiratory allergies, have been published in the research journal, The Lancet Regional Health – Europe (https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(21)00261-1/fulltext) – a regionally-focused…

AI, Collaborations, Competitor News, Oncology, Product Updates

Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence

Posted on

December 01, 2021 07:21 AM Eastern Standard Time BURLINGTON, N.C. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Labcorp (NYSE: LH), a leading global life sciences company, and ConcertAI, LLC (ConcertAI), a leader in enterprise artificial intelligence (AI) and real-world data (RWD) solutions for life science companies and health care providers, today announced a collaboration to optimize…